SPY401.16-0.56 -0.14%
DIA321.91-0.32 -0.10%
IXIC11,779.20-25.80 -0.22%

--BMO Capital Adjusts Eli Lilly and Company Price Target to $358 From $330, Maintains Outperform Rating

MT Newswires · 04/29/2022 09:16

Please log in to view news